| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_551538aa93b7a285af2df8da7fa60014 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91057 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12 |
| filingDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad0b8b8cbd99622681fdde4f5e0a3ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb549ffb2367d3122e06b8e1801c8833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6d28600e7974f1ea5ae635fc0e9fcaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0e30854f059745772c931c486bf0628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6f06dc0a918b8857e16f8a802786ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d987de3b8810d52f50978ddf34e73b5 |
| publicationDate |
2010-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010173982-A1 |
| titleOfInvention |
Novel method for the asymmetric synthesis of beta-lactone compounds |
| abstract |
The present invention features methods of treating a cancer in a subject by administering an effective amount of a beta-lactone to the subject. The invention also features methods of inhibiting angiogenesis in a subject by administering an effective amount of an inhibitor of fatty acid synthase to the subject. These methods can be used to treat a variety of cancers and other diseases and conditions. The invention also features methods of identifying beta-lactones and other compounds that can be used in the methods of the invention for the treatment of tumors, inhibition of angiogenesis, and the treatment of diseases and conditions that involve pathological angiogenesis. The invention also features methods of synthesizing beta-lactones and features novel beta-lactone compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013152272-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015031300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013070966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104245653-A |
| priorityDate |
2002-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |